Santa Cruz Biotechnology provides a broad selection of CYP2B1 monoclonal antibodies for research applications. CYP2B1 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP2B1, a member of the cytochrome P450 family, plays a crucial role in the metabolism of various xenobiotics and endogenous compounds. Its function is essential for drug metabolism and the detoxification processes in the liver, making it a significant target for studies related to pharmacology and toxicology. Understanding the expression and regulation of CYP2B1 can provide insights into individual variations in drug response and susceptibility to toxic substances. Researchers frequently utilize CYP2B1 monoclonal antibodies to investigate metabolic pathways and drug interactions in liver tissue. The specificity of CYP2B1 monoclonal antibodies enables precise detection and quantification in complex biological samples. CYP2B1 monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing our understanding of drug metabolism and toxicology.